Showing results (181-190 of 421) with videos related to
Sort By:
Pageof 43
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2009
Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancerJoke Beuten, Jonathan A L Gelfond, Jennifer L Franke, et al.Carcinogenesis|June 17, 2009
Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic menJoke Beuten, Jonathan A L Gelfond, Margarita L Martinez-Fierro, et al.The Prostate|November 26, 2009
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention TrialAlan R Kristal, Douglas K Price, Cathee Till, et al.The Prostate|July 12, 2008
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trialMarian L Neuhouser, Jeannette Schenk, Yoon Ju Song, et al.Journal of the National Cancer Institute|April 20, 2006
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.Journal of Geriatric Oncology|August 3, 2020
A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancerScott D Ramsey, Ingrid J Hall, Judith Lee Smith, et al.Urology|November 10, 2007
Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mLEdith Canby-Hagino, Javier Hernandez, Timothy C Brand, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionM Scott Lucia, Amy K Darke, Phyllis J Goodman, et al.American Journal of Epidemiology|April 27, 2011
Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trialTheodore M Brasky, Cathee Till, Emily White, et al.The Journal of Urology|March 27, 2007
Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Jeannette M Schenk, et al.Pageof 43